1. Home
  2. PTCT vs MTRN Comparison

PTCT vs MTRN Comparison

Compare PTCT & MTRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PTC Therapeutics Inc.

PTCT

PTC Therapeutics Inc.

HOLD

Current Price

$75.18

Market Cap

5.7B

Sector

Health Care

ML Signal

HOLD

Logo Materion Corporation

MTRN

Materion Corporation

HOLD

Current Price

$247.87

Market Cap

5.1B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
PTCT
MTRN
Founded
1998
1931
Country
United States
United States
Employees
N/A
2880
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Specialties
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
5.7B
5.1B
IPO Year
2006
2000

Fundamental Metrics

Financial Performance
Metric
PTCT
MTRN
Price
$75.18
$247.87
Analyst Decision
Buy
Buy
Analyst Count
17
4
Target Price
$80.65
$52.50
AVG Volume (30 Days)
1.0M
259.0K
Earning Date
05-07-2026
04-29-2026
Dividend Yield
N/A
0.32%
EPS Growth
264.48
1178.57
EPS
N/A
0.92
Revenue
$264,734,000.00
N/A
Revenue This Year
N/A
$15.31
Revenue Next Year
$17.70
$7.57
P/E Ratio
N/A
$267.39
Revenue Growth
36.19
N/A
52 Week Low
$43.18
$76.09
52 Week High
$87.50
$247.03

Technical Indicators

Market Signals
Indicator
PTCT
MTRN
Relative Strength Index (RSI) 60.42 71.67
Support Level $73.41 $116.88
Resistance Level $79.67 N/A
Average True Range (ATR) 2.59 10.02
MACD 0.43 0.90
Stochastic Oscillator 90.99 77.87

Price Performance

Historical Comparison
PTCT
MTRN

About PTCT PTC Therapeutics Inc.

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.

About MTRN Materion Corporation

Materion Corp offers products that include precious and non-precious specialty metals, inorganic chemicals and powders, specialty coatings, specialty engineered beryllium and copper-based alloys, beryllium composites, ceramics, and engineered clad and plated metal systems. Its segments are: Performance Materials provides beryllium and non-beryllium containing alloy systems and custom engineered parts. Electronic Materials produces chemicals, microelectronics packaging, and specialty metal products, including vapor deposition targets and preforms. Precision Optics produces thin film coatings and optical filter materials. The Other reportable segment includes unallocated corporate costs and assets. It operates in the United States, Asia, Europe, and other countries.

Share on Social Networks: